Many of our pioneering systems are designed to exceed HTA criteria.
Many of our pioneering systems are designed to exceed HTA criteria.
BioVault has achieved a number of accreditations and forged relationships with numerous bodies since 2002, all designed to test the robustness of our internal procedures and reassure clients they are being given the highest levels of quality and service.
Many of BioVault's pioneering systems have been designed to exceed the criteria set out by the Human Tissue Authority (HTA) with whom we work closely. The HTA is the competent authority under the European Tissue and Cell Directive and sets the standards for regulating human tissue application establishments.
Licences, accreditations and memberships include:
HTA
BioVault is now the UKs only private human tissue bank (and one of very few public human tissue banks) to hold an open ended, unconditional HTA licence which covers every aspect of all transplantable material for human application. For more detail concerning BioVault's HTA licence, click here.
(licence no: 11063)
ISO 9001:2000
The internationally recognised standard for an organisation's internal Quality Management.
(certificate no: GB04/62552)
ISO 13485
Quality management standards for medical devices
(certificate no: GB07/72849)
NEQAS
BioVault's Flow Cytometers are externally quality controlled by NEQAS .
British Association of Tissue Banks
BioVault is an established member of the British Association of Tissue Banks
MHRA
Prior to the introduction of the HTA in 2006, BioVault was accredited under the preferred voluntary code audited, administered and validated by the MHRA. The MHRA no longer has any regulatory responsibility for human tissue banks.
OHIM
Biovault has been issued the Certificate of Registration for the Community Trade Mark as of 24.12.2009 by The Office of Harmonization for the Internal Market. This is valid in all 27 countries of the EU.
BIOVAULT© 2009 PIONEERING STEM CELL & TISSUE BANKING